カテゴリー： QYResearch, 世界

腫瘍壊死因子(TNF)阻害薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X19054）・商品コード：DATA909X19054
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、腫瘍壊死因子(TNF)阻害薬の世界市場について調査・分析し、腫瘍壊死因子(TNF)阻害薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー）、用途別（関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の腫瘍壊死因子(TNF)阻害薬市場動向
・主要企業別マーケットシェア
・腫瘍壊死因子(TNF)阻害薬の種類別市場規模2014-2019
（ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー）
・腫瘍壊死因子(TNF)阻害薬の用途別市場規模2014-2019
（関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他）
・腫瘍壊死因子(TNF)阻害薬の北米市場：主要企業・種類別/用途別市場規模
・腫瘍壊死因子(TNF)阻害薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・腫瘍壊死因子(TNF)阻害薬の中国市場：主要企業・種類別/用途別市場規模
・腫瘍壊死因子(TNF)阻害薬の日本国内市場：主要企業・種類別/用途別市場規模
・腫瘍壊死因子(TNF)阻害薬の東南アジア市場：主要企業・種類別/用途別市場規模
・腫瘍壊死因子(TNF)阻害薬のインド市場：主要企業・種類別/用途別市場規模
・腫瘍壊死因子(TNF)阻害薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（AbbVie Inc.、Amgen Inc.、Johnson & Johnson Services, Inc.、UCB S.A.、Novartis International AG、Pfizer, Inc.、Merck & co., Inc.）
・腫瘍壊死因子(TNF)阻害薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their treatment. The important side effects of TNF inhibitors include lymphomas, infections (especially reactivation of latent tuberculosis), congestive heart failure, demyelinating disease, a lupus-like syndrome, induction of auto-antibodies, injection site reactions, and systemic side effects.The market growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune diseases, and a significant rise in consumer awareness regarding Tumor Necrosis Factor (TNF).
In 2018, the global Tumor Necrosis Factor (TNF) Inhibitor Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tumor Necrosis Factor (TNF) Inhibitor Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Necrosis Factor (TNF) Inhibitor Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AbbVie Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
UCB S.A.
Novartis International AG
Pfizer, Inc.
Merck & co., Inc.
…

Market segment by Type, the product can be split into
Humira
Enbrel
Remicade
Simponi/Simponi Aria
Cimzia
Biosimilars

Market segment by Application, split into
Rheumatoid Arthritis
Psoriasis
Psoriatic Arthritis
Crohn’s Disease
Ulcerative Colitis
Ankylosing Spondylitis
Juvenile Idiopathic Arthritis
Hidradenitis Suppurativa
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tumor Necrosis Factor (TNF) Inhibitor Drugs status, future forecast, growth opportunity, key market and key players.
To present the Tumor Necrosis Factor (TNF) Inhibitor Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tumor Necrosis Factor (TNF) Inhibitor Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Humira
1.4.3 Enbrel
1.4.4 Remicade
1.4.5 Simponi/Simponi Aria
1.4.6 Cimzia
1.4.7 Biosimilars
1.5 Market by Application
1.5.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application (2019-2025)
1.5.2 Rheumatoid Arthritis
1.5.3 Psoriasis
1.5.4 Psoriatic Arthritis
1.5.5 Crohn’s Disease
1.5.6 Ulcerative Colitis
1.5.7 Ankylosing Spondylitis
1.5.8 Juvenile Idiopathic Arthritis
1.5.9 Hidradenitis Suppurativa
1.5.10 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size
2.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Growth Trends by Regions
2.2.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Regions (2019-2025)
2.2.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by by Players
3.1.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by by Players (2014-2019)
3.1.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players Head office and Area Served
3.3 Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Product/Solution/Service
3.4 Date of Enter into Tumor Necrosis Factor (TNF) Inhibitor Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2014-2019)
4.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2014-2019)
5.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players in North America
5.3 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
5.4 North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application

6 Europe
6.1 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2014-2019)
6.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players in Europe
6.3 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
6.4 Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application

7 China
7.1 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2014-2019)
7.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players in China
7.3 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
7.4 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application

8 Japan
8.1 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2014-2019)
8.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players in Japan
8.3 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
8.4 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2014-2019)
9.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players in Southeast Asia
9.3 Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
9.4 Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application

10 India
10.1 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2014-2019)
10.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players in India
10.3 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
10.4 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size (2014-2019)
11.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Players in Central & South America
11.3 Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type
11.4 Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application

12 International Players Profiles
12.1 AbbVie Inc.
12.1.1 AbbVie Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
12.1.4 AbbVie Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019))
12.1.5 AbbVie Inc. Recent Development
12.2 Amgen Inc.
12.2.1 Amgen Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
12.2.4 Amgen Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
12.2.5 Amgen Inc. Recent Development
12.3 Johnson & Johnson Services, Inc.
12.3.1 Johnson & Johnson Services, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
12.3.4 Johnson & Johnson Services, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
12.3.5 Johnson & Johnson Services, Inc. Recent Development
12.4 UCB S.A.
12.4.1 UCB S.A. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
12.4.4 UCB S.A. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
12.4.5 UCB S.A. Recent Development
12.5 Novartis International AG
12.5.1 Novartis International AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
12.5.4 Novartis International AG Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
12.5.5 Novartis International AG Recent Development
12.6 Pfizer, Inc.
12.6.1 Pfizer, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
12.6.4 Pfizer, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
12.6.5 Pfizer, Inc. Recent Development
12.7 Merck & co., Inc.
12.7.1 Merck & co., Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Introduction
12.7.4 Merck & co., Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
12.7.5 Merck & co., Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Tumor Necrosis Factor (TNF) Inhibitor Drugs Key Market Segments
Table Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Covered
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Humira Figures
Table Key Players of Humira
Figuer Enbrel Figures
Table Key Players of Enbrel
Figuer Remicade Figures
Table Key Players of Remicade
Figuer Simponi/Simponi Aria Figures
Table Key Players of Simponi/Simponi Aria
Figuer Cimzia Figures
Table Key Players of Cimzia
Figuer Biosimilars Figures
Table Key Players of Biosimilars
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application in 2018 & 2025
Figure Rheumatoid Arthritis Case Studies
Figure Psoriasis Case Studies
Figure Psoriatic Arthritis Case Studies
Figure Crohn’s Disease Case Studies
Figure Ulcerative Colitis Case Studies
Figure Ankylosing Spondylitis Case Studies
Figure Juvenile Idiopathic Arthritis Case Studies
Figure Hidradenitis Suppurativa Case Studies
Figure Others Case Studies
Figure Tumor Necrosis Factor (TNF) Inhibitor Drugs Report Years Considered
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions 2014-2019
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions 2014-2019
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by by Players (2014-2019)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by by Players in 2018
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Product/Solution/Service
Table Date of Enter into Tumor Necrosis Factor (TNF) Inhibitor Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Share by Type (2014-2019)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Market Share by Type (2014-2019)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Share by Application (2014-2019)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Market Share by Application (2014-2019)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share by Application in 2018
Figure North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share (2018-2019)
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type 2014-2019
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application 2014-2019
Figure Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share (2018-2019)
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type 2014-2019
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application 2014-2019
Figure China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share (2018-2019)
Table China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 2014-2019 (Million US$)
Table China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type 2014-2019
Table China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 2014-2019 (Million US$)
Table China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application 2014-2019
Figure Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share (2018-2019)
Table Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type 2014-2019
Table Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application 2014-2019
Figure Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share (2018-2019)
Table Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type 2014-2019
Table Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application 2014-2019
Figure India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share (2018-2019)
Table India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 2014-2019 (Million US$)
Table India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type 2014-2019
Table India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 2014-2019 (Million US$)
Table India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application 2014-2019
Figure Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share (2018-2019)
Table Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Type 2014-2019
Table Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Share by Application 2014-2019
Table AbbVie Inc. Company Details
Table AbbVie Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business 2014-2019 (Million US$)
Figure AbbVie Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
Table AbbVie Inc. Recent Development
Table Amgen Inc. Company Details
Table Amgen Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business 2014-2019 (Million US$)
Figure Amgen Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
Table Amgen Inc. Recent Development
Table Johnson & Johnson Services, Inc. Company Details
Table Johnson & Johnson Services, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business 2014-2019 (Million US$)
Figure Johnson & Johnson Services, Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
Table Johnson & Johnson Services, Inc. Recent Development
Table UCB S.A. Company Details
Table UCB S.A. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business 2014-2019 (Million US$)
Figure UCB S.A. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
Table UCB S.A. Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business 2014-2019 (Million US$)
Figure Novartis International AG Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
Table Novartis International AG Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business 2014-2019 (Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Merck & co., Inc. Company Details
Table Merck & co., Inc. Revenue in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business 2014-2019 (Million US$)
Figure Merck & co., Inc. Revenue Growth Rate in Tumor Necrosis Factor (TNF) Inhibitor Drugs Business (2014-2019)
Table Merck & co., Inc. Recent Development
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Share by Regions (2019-2025)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Share by Regions in 2025
Figure North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Product (2019-2025)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Product in 2025
Table Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application (2019-2025)
Figure Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AbbVie Inc.、Amgen Inc.、Johnson & Johnson Services, Inc.、UCB S.A.、Novartis International AG、Pfizer, Inc.、Merck & co., Inc.

★調査レポート[腫瘍壊死因子(TNF)阻害薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X19054)販売に関する免責事項を必ずご確認ください。
★調査レポート[腫瘍壊死因子(TNF)阻害薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 血管内皮増殖因子(VEGF)阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X19071 / QYResearch / 2019年11月25日 / ※当調査レポートでは、血管内皮増殖因子(VEGF)阻害剤の世界市場について調査・分析し、血管内皮増殖因子(VEGF)阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別（腫瘍学、眼科）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の血管内皮増殖因子(VEGF)阻害剤市場動向 ・主要企業別マーケットシェア ・血管内皮増殖因子(VEGF)阻害剤の種類別市場規模2014-2019 （VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤） ・血管内皮増殖因子(VEGF)阻害剤の用途別市場規模2014-2019 （腫瘍学、眼科） ・血管内皮増殖因子(VEGF)阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・血管内皮増殖因子(VEGF)阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of vascular endothelial growth factor can generate cancerous cells. In 2018, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Vascular Endothelial Growth Factor (VEGF) Inhibitors status,...
  • 多要素認証技術の世界市場：規模・現状・予測2019-2025
    DATA909X18730 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多要素認証技術の世界市場について調査・分析し、多要素認証技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（2因子、3因子、4因子、5因子）、用途別（医療、金融機関、政府、エンターテインメント、通信、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多要素認証技術市場動向 ・主要企業別マーケットシェア ・多要素認証技術の種類別市場規模2014-2019 （2因子、3因子、4因子、5因子） ・多要素認証技術の用途別市場規模2014-2019 （医療、金融機関、政府、エンターテインメント、通信、その他） ・多要素認証技術の北米市場：主要企業・種類別/用途別市場規模 ・多要素認証技術のヨーロッパ市場：主要企業・種類別/用途別市場規模...Multi-factor authentication (MFA) is an authentication method in which a computer user is granted access only after successfully presenting two or more pieces of evidence (or factors) to an authentication mechanism: knowledge (something the user and only the user knows), possession (something the user and only the user has), and inherence (something the user and only the user is).Multi-factor authentication (MFA) is a method of computer access control. Users need to pass two or more authentication mechanisms before they can get authorization to use computer resources. For example, a user needs to enter a PIN code, insert a bank card,...
  • 腫瘍高周波アブレーションの世界市場：規模・現状・予測2019-2025
    DATA909X19055 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍高周波アブレーションの世界市場について調査・分析し、腫瘍高周波アブレーションの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他）、用途別（病院、がん専門クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍高周波アブレーション市場動向 ・主要企業別マーケットシェア ・腫瘍高周波アブレーションの種類別市場規模2014-2019 （肺がん、腎臓がん、乳がん、前立腺がん、肝臓がん、その他） ・腫瘍高周波アブレーションの用途別市場規模2014-2019 （病院、がん専門クリニック、その他） ・腫瘍高周波アブレーションの北米市場：主要企業・種類別/用途別市場規模 ・腫瘍高周波アブレーションのヨーロッパ市場：主要企業・種類別/用途別市場規模...Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area.In 2018, the global Tumor Radiofrequency Ablation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Tumor Radiofrequency Ablation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Radiofrequency Ablation development...

    • ◆H&Iグローバルリサーチのお客様（例）◆